Advertisement
Singapore markets closed
  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • Bitcoin USD

    60,603.22
    -1,563.45 (-2.51%)
     
  • CMC Crypto 200

    1,254.65
    -103.36 (-7.61%)
     
  • S&P 500

    5,221.69
    +7.61 (+0.15%)
     
  • Dow

    39,499.39
    +111.63 (+0.28%)
     
  • Nasdaq

    16,339.82
    -6.44 (-0.04%)
     
  • Gold

    2,374.40
    +34.10 (+1.46%)
     
  • Crude Oil

    78.32
    -0.94 (-1.19%)
     
  • 10-Yr Bond

    4.5020
    +0.0530 (+1.19%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

GW Pharmaceuticals: Q3 Performance, Q4 Estimates

GW Pharmaceuticals: Q3 Performance, Q4 Estimates

GW Pharmaceuticals (GWPH) is a leader in the development of plant-derived cannabinoid therapeutics. GW Pharmaceuticals reported EPS of -$1.26 on revenues of $3.46 million in the third quarter. It was a 10.2% revenue growth year-over-year.